Russian diabetes market to grow to $1.7 billion

October 17, 2011
Sales and Marketing Russia, diabetes

Russia’s diabetes market is set be worth $1.7 billion by 2015, according to a new report. Industry analysts Decision Resources’ …

Frontera appoints creative director

October 14, 2011
Medical Communications appointment, medical communications

Covent Garden-based comms agency Frontera has appointed Bruno Cepollina as creative director. The former creative partner at McCann Healthcare is …

Health service’s £1bn patent expiry windfall

October 14, 2011
Sales and Marketing generics, patent expiry

Patent expiries could shave £1 billion from  the NHS drugs bill, and could yield major savings by 2015 for the …

Pfizer to research prescription drug costs for the elderly

October 14, 2011
Sales and Marketing Pfizer

Pfizer has signed a five-year research pact with US healthcare insurer Humana to investigate treatment costs for the elderly. The …

Genzyme completes expansion at Waterford plant

October 14, 2011
Manufacturing and Production Genzyme, Sanofi

Sanofi’s Genzyme unit has officially opened a €150 million expansion at its ten-year-old biotechnology facility in Waterford, Ireland that will …

Yervoy

NICE: Bristol-Myers Squibb’s Yervoy too costly

October 14, 2011
Sales and Marketing NICE, Yervoy

Bristol Myers Squibb has failed to win NICE backing for its melanoma drug Yervoy after the Institute judged its £80,000 …

Avastin

NHS regions back Avastin for eye disease

October 14, 2011
Sales and Marketing avastin

Regional NHS authorities around England are approving the use of Avastin instead of Lucentis for ophthalmology patients. A number of …

Kindle Fire

Keep taking the tablets

October 13, 2011
Sales and Marketing ipad, tablet pc

Online giant Amazon has just launched Fire, its rival to Apple’s trendsetting iPad, upping the ante in the ‘tablet’ market. …

Roche

Roche revenue drops as key products underperform

October 13, 2011
Sales and Marketing Roche

Roche has posted worse-than-expected figures for the first nine months of this year after key products failed to shine and …

NICE recommends RoActemra for early use in arthritis

October 13, 2011
Sales and Marketing NICE, RoActemra

NICE has recommended Roche’s drug RoActemra be used at an earlier stage for some arthritis patients. In draft guidance NICE …

Lords’ Health Bill challenge fails

October 12, 2011
NHS reform

The government’s NHS reforms have survived a challenge in the House of Lords that have delayed them until the next …

Bayer planning joint venture to make drugs in Russia

October 12, 2011
Manufacturing and Production Bayer, pharma manufacturing news

Germany’s Bayer AG has joined a number of its peers in the pharmaceutical industry with the signing of an agreement …

Europe

Pharmacovigilance at heart of EC patient information proposals

October 12, 2011
Medical Communications, Sales and Marketing patient information

Pharmacovigilance is at the centre of revised proposals announced this week setting out what information pharma firms can put on …

Charities support new electronic patient records

October 12, 2011
Sales and Marketing IT, NHS, electronic patient records

The troubled project to launch an NHS-wide electronic patient record system has received new support from patient groups.The Summary Care …

Quintiles opens new European headquarters in the UK

October 12, 2011
Research and Development Quintiles, research and development news

Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …

Peers to vote on delaying the Health Bill

October 12, 2011
NHS reforms

The government’s health reforms face the prospect of a significant delay if a vote today goes against them. Peers in …

MS audit finds little improvement in care

October 12, 2011
MS, multiple sclerosis

There has been “little or no improvement” in the care of multiple sclerosis patients over the past five years, according …

Pharma manufacturing news in brief

October 12, 2011
Manufacturing and Production pharma manufacturing news

FDA sets aside $35m for manufacturing research, Anteco, Apicore and Vetter provide facility updates and Domino Printing sets up a …

Stallergenes Moves to the Cloud with Veeva CRM

October 11, 2011

BARCELONA, SPAIN — 11 October, 2011 – Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace …

India

India will scrutinise foreign investment in pharma

October 11, 2011
Manufacturing and Production, Research and Development, Sales and Marketing India, Indian pharmaceutical industry

The Indian government has decided not to put any restrictions on the level of foreign direct investment (FDI) in the …

The Gateway to Local Adoption Series

Latest content